Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01071707
What this trial is testing

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 108
Not applicableStudy completedNCT01107028
What this trial is testing

Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
National Jewish Health 41
Not applicableUnknownNCT06527612
What this trial is testing

The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients

Who this might be right for
Fibrosis, PulmonaryPulmonary Rehabilitation
Istanbul Medipol University Hospital 56
Not applicableStudy completedNCT03411876
What this trial is testing

Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Klaus Kenn 22
Testing effectiveness (Phase 2)Ended earlyNCT04652518
What this trial is testing

LYT-100 in Post-acute COVID-19 Respiratory Disease

Who this might be right for
Covid19Post-acute COVID-19 Respiratory Disease
PureTech 185
Early research (Phase 1)Ended earlyNCT02052297
What this trial is testing

A Validation and Dosimetry Study of GSK2634673F PET Ligand

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 19
Testing effectiveness (Phase 2)WithdrawnNCT05951296
What this trial is testing

Investigate Leramistat in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Modern Biosciences Ltd
Testing effectiveness (Phase 2)Study completedNCT06241560
What this trial is testing

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 20
Not applicableLooking for participantsNCT07466420
What this trial is testing

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

Who this might be right for
Fibrotic Interstitial Lungs DiseasesIdiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Katerina M. Antoniou 100
Not applicableStudy completedNCT03901196
What this trial is testing

Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)

Who this might be right for
Interstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary Fibrosis
University Hospital, Grenoble 86
Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05321420
What this trial is testing

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
PureTech 240
Not applicableStudy completedNCT06650774
What this trial is testing

Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Karadeniz Technical University 152
Early research (Phase 1)Study completedNCT04069143
What this trial is testing

Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

Who this might be right for
Healthy ParticipantsIdiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 14
Large-scale testing (Phase 3)Study completedNCT04429516
What this trial is testing

Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 44
Not applicableLooking for participantsNCT06815185
What this trial is testing

Rehabilitation Counselling for Patients with Interstitial Lung Disease

Who this might be right for
Fibrosis, Pulmonary
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableActive Not RecruitingNCT02772549
What this trial is testing

Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay

Who this might be right for
Idiopathic Pulmonary Fibrosis
Nils Hoyer 300
Not applicableNot Yet RecruitingNCT06980844
What this trial is testing

Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies

Who this might be right for
Interstitial Lung Disease
Hopital Foch 60
Not applicableLooking for participantsNCT07345052
What this trial is testing

Western Sweden Systemic Sclerosis Project

Who this might be right for
Scleroderma, SystemicFibrosis; SkinFibrosis Lung+1 more
Sahlgrenska University Hospital 150
Next Page